نتایج جستجو برای: naftopidil
تعداد نتایج: 104 فیلتر نتایج به سال:
A wide array of drugs are available for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH), but the evidence for the comparative effectiveness is controversial.The objective of this study is to evaluate the comparative effectiveness and safety of monodrug therapies for BPH.Data sources are MEDLINE, EMBASE, and the Cochrane Library.We included random...
PURPOSE To determine if switching from one brand of the α1-adrenoceptor antagonist naftopidil (Avishot™) to another brand (Flivas™) under the same conditions causes the same changes in lower urinary tract symptoms (LUTS) and quality of life (QOL) as the perceived placebo effect, and if ambient temperature as a nonspecific factor is related to those changes in benign prostatic hyperplasia (BPH) ...
Hypothesis / aims of study It is clinically known that anticholinergic agents, commonly used for treating overactive bladder, etc., act on the muscarinic receptor in salivary glands, causing dry mouth as an adverse effect. Not only the muscarinic receptor but also the α1-adrenergic receptor are present in human salivary glands, and are thought to accelerate saliva production. The common adverse...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید